To include your compound in the COVID-19 Resource Center, submit it here.

Muraglitazar: Phase III data

In the placebo-controlled Phase III trial in 449 treatment-naïve patients, muraglitazar met the primary

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE